Need Help?
Copied to clipboard!

Spatial Profiling Uncovers a High-Risk Stromal-Fibrotic Subtype in Hormone Receptor-Positive, HER2-Negative Breast Cancer

This study characterizes the spatial transcriptomic landscape of treatment-naive hormone receptor-positive, HER2-negative invasive breast carcinomas of no special type. Spatial transcriptomic profiling was performed on 86 tumors from 85 patients and integrated with histopathological annotation and cell-type deconvolution. The analyses were used to identify spatially defined molecular and microenvironmental patterns and to derive the Spatial4HR+ subtypes. These subtypes were subsequently evaluated for biological characteristics and clinical outcome associations.

Cite

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD50000003198 Illumina NovaSeq 6000 87